Freeslate Biologics Formulation Summit Highlights Best Practices in High Throughput Research and Data Management

Share Article

Mind-sharing Among Industry Leaders Included Case Studies, High Throughput Lab Tour, and Strategic Discussions

We’re pleased that we can support leaders in biologics formulation coming together to have an open dialogue on the challenges and opportunities for making dramatic improvements in their productivity.

Freeslate, Inc., the leading provider of high throughput research solutions for biopharmaceutical development, today announced highlights of its Biologics Formulation Summit held May 20 - 21, 2014 at Janssen Pharmaceutical in Malvern, Pennsylvania. The meeting featured a tour of the Janssen high throughput lab, customer case studies, and discussions of best practices in high throughput research and data management.

At this year’s Biologics Formulation Summit, scientists gathered to discuss the challenges and opportunities of formulation development and bring knowledge about best practices back to their organizations. The summit consisted of case-study presentations by a diverse set of customers including Janssen Pharmaceutical, Novo Nordisk, KBI Biopharma, and Amgen, who highlighted their experience with Freeslate products to achieve dramatic innovation and rapid return on investment. Hands-on training sessions were given by Freeslate staff who focused on accelerating productivity. A tour of the Janssen facilities allowed attendees to see automation tools at work and discuss specific implementation with scientists and technicians. Networking between sessions and at evening events offered opportunities for one-on-one discussion and exchanging of new strategies and ideas.

“Developing biologic drug products has always been a complex challenge, and today, the demands placed on development organizations are only increasing,” said John S. Senaldi, President and CEO of Freeslate. “We’re pleased that we can support leaders in biologics formulation coming together to have an open dialogue on the challenges and opportunities for making dramatic improvements in their productivity.”

Formulation development labs are under growing pressure to increase productivity due to a number of factors: an increasing number of biologics candidates, implementation of Quality by Design (QbD) initiatives requiring a broader understanding of the formulation design space, and reduced available resources. All these factors are pushing formulation chemists to achieve significant productivity gains. Freeslate is the leader in high throughput research solutions for drug development. Through collaborations with pharmaceutical/biotechnology R&D organizations, Freeslate has developed a unique high throughput research approach to address the challenges in biologics formulation.

Additional information about the Biologics Formulation Summit can be found by visiting

About Freeslate

Freeslate is a privately held company providing laboratory automation products that dramatically improve the productivity and innovation of drug development organizations. For more than a decade, Freeslate has been working with customers to automate complex chemical research processes. Our resulting product line includes solutions for protein and vaccine drug formulation development, small molecule solubility, and polymorph screening and process chemistry. We start with a scientific understanding of our customer’s bottlenecks and utilize our robust and proprietary automation platforms and integrated Lab Execution and Analysis (LEA) software suite to deliver solutions that make a difference. The company is headquartered in Sunnyvale, California, with direct sales and service in North America, Europe, and Asia. For more information, visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mikelle Thatcher
Visit website